Share on StockTwits

Perrigo Company PLC (NASDAQ:PRGO) CFO Judy L. Brown sold 4,827 shares of the stock on the open market in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $148.87, for a total value of $718,595.49. Following the transaction, the chief financial officer now directly owns 7,445 shares in the company, valued at approximately $1,108,337. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Perrigo Company PLC (NASDAQ:PRGO) traded up 0.81% on Thursday, hitting $150.03. The stock had a trading volume of 709,588 shares. Perrigo Company PLC has a 52 week low of $117.80 and a 52 week high of $168.39. The stock’s 50-day moving average is $149.7 and its 200-day moving average is $148.7. The company has a market cap of $20.077 billion and a P/E ratio of 84.08.

Perrigo Company PLC (NASDAQ:PRGO) last announced its earnings results on Thursday, August 14th. The company reported $1.74 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. On average, analysts predict that Perrigo Company PLC will post $7.39 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 16th. Investors of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, August 27th.

PRGO has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Perrigo Company PLC currently has an average rating of “Buy” and an average target price of $166.92.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.